Mixture of Finite Mixtures Model for Basket Trial
Fuente:
arXiv
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Preprint |
| Published: |
2020
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866913108281262080 |
|---|---|
| author | Geng, Junxian Zhou, Tianjian Lin, Ruitao Hu, Guanyu |
| author_facet | Geng, Junxian Zhou, Tianjian Lin, Ruitao Hu, Guanyu |
| contents | With the recent paradigm shift from cytotoxic drugs to new generation of target therapy and immuno-oncology therapy during oncology drug developments, patients with various cancer (sub)types may be eligible to participate in a basket trial if they have the same molecular target. Bayesian hierarchical modeling (BHM) are widely used in basket trial data analysis, where they adaptively borrow information among different cohorts (subtypes) rather than fully pool the data together or doing stratified analysis based on each cohort. Those approaches, however, may have the risk of over shrinkage estimation because of the invalidated exchangeable assumption. We propose a two-step procedure to find the balance between pooled and stratified analysis. In the first step, we treat it as a clustering problem by grouping cohorts into clusters that share the similar treatment effect. In the second step, we use shrinkage estimator from BHM to estimate treatment effects for cohorts within each cluster under exchangeable assumption. For clustering part, we adapt the mixture of finite mixtures (MFM) approach to have consistent estimate of the number of clusters. We investigate the performance of our proposed method in simulation studies and apply this method to Vemurafenib basket trial data analysis. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2011_04135 |
| institution | arXiv |
| publishDate | 2020 |
| record_format | arxiv |
| spellingShingle | Mixture of Finite Mixtures Model for Basket Trial Geng, Junxian Zhou, Tianjian Lin, Ruitao Hu, Guanyu Methodology Applications With the recent paradigm shift from cytotoxic drugs to new generation of target therapy and immuno-oncology therapy during oncology drug developments, patients with various cancer (sub)types may be eligible to participate in a basket trial if they have the same molecular target. Bayesian hierarchical modeling (BHM) are widely used in basket trial data analysis, where they adaptively borrow information among different cohorts (subtypes) rather than fully pool the data together or doing stratified analysis based on each cohort. Those approaches, however, may have the risk of over shrinkage estimation because of the invalidated exchangeable assumption. We propose a two-step procedure to find the balance between pooled and stratified analysis. In the first step, we treat it as a clustering problem by grouping cohorts into clusters that share the similar treatment effect. In the second step, we use shrinkage estimator from BHM to estimate treatment effects for cohorts within each cluster under exchangeable assumption. For clustering part, we adapt the mixture of finite mixtures (MFM) approach to have consistent estimate of the number of clusters. We investigate the performance of our proposed method in simulation studies and apply this method to Vemurafenib basket trial data analysis. |
| title | Mixture of Finite Mixtures Model for Basket Trial |
| topic | Methodology Applications |
| url | https://arxiv.org/abs/2011.04135 |